Concepedia

Jill Beyer

JB

Statistics

Publications

49

Citations

3.5K

H-Index

32

Active since

1977

Affiliations

Abbott Fund(Current)

AbbVie (United States)

Abbott (United Kingdom)

Abbott (United States)

Hiroshima University

Jill Beyer is an author at Abbott Fund specializing in life sciences, infectious diseases, and microbiology.

Publications per year

1977–2022

49

Publications

49

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori

James Versalovic, Dee Shortridge, K. Kibler et al. · Antimicrobial Agents and Chemotherapy · 1996 · 504 citations · Full text

, , +17

Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides

Dwight J. Hardy, Dena M. Hensey, Jill Beyer et al. · Antimicrobial Agents and Chemotherapy · 1988 · 302 citations

, , +16

Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994-1995

Virginia D. Shortridge, Gary V. Doern, Angela B. Brueggemann et al. · Clinical Infectious Diseases · 1999 · 177 citations · Full text

, , +17

A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori

Gregory G. Stone, Dee Shortridge, James Versalovic et al. · Antimicrobial Agents and Chemotherapy · 1997 · 163 citations · Full text

, , +17

<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Teresa I. Ng, Preethi Krishnan, Warren M. Kati et al. · Antimicrobial Agents and Chemotherapy · 2017 · 139 citations · Full text

, , +17

1–5 of 49